We are thrilled to announce that DeepTrace Technologies and Gleamer have joined EIBIR as our newest industry partners. We are excited about the possibilities and collaborations that these partnerships will bring, and we look forward to exploring how we can work together to advance biomedical imaging research and innovation.
About DeepTrace Technologies
DeepTrace Technologies emerged in 2015 after two pioneering Italian researchers demonstrated the potential of artificial intelligence in predicting Alzheimer’s disease through in-vivo brain imaging. This breakthrough prompted the creation of a startup aimed at bridging the gap between science and society. Since its beginning, DeepTrace has grown to include a team of passionate researchers dedicated to translating intelligent technologies into groundbreaking products for the benefit of society.
About Gleamer
Gleamer is at the forefront of medical imaging innovation, committed to developing a comprehensive AI copilot to facilitate precision medicine. Their AI applications are designed to meet daily clinical needs, offering a seamless experience integrated into existing workflows. Gleamer’s solutions, which currently support X-rays of bones and the chest, will soon extend to mammography and CT scans. Known for their high standards of performance and patient data security, Gleamer has earned accolades such as the Best New Radiology Vendor Award at the EuroMinnies and a top 10 finish in Google’s EMEA AI contest in 2023.
EIBIR is excited to welcome these innovative companies into our community. We believe that the combined expertise and cutting-edge technologies of DeepTrace Technologies and Gleamer will significantly enhance our collaborative efforts to drive advancements in biomedical imaging. Together, we look forward to making strides in research that will benefit patients and healthcare providers.
Stay tuned for more updates on our collaborations and the impactful projects that will emerge from these new partnerships.